Antihypertensive agents. Synthesis and biological properties of 2-amino-4-aryl-2-imidazolines.
D000588:Amines / Q000138:chemical synthesis / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D001763:Blepharoptosis / Q000517:prevention & control; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D006168:Guinea Pigs; D007093:Imidazoles / Q000138:chemical synthesis* / Q000494:pharmacology; D066298:In Vitro Techniques; D007583:Jejunum / Q000294:innervation; D008297:Male; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism; D009474:Neurons / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D012110:Reserpine / Q000037:antagonists & inhibitors; D012669:Seminal Vesicles / Q000187:drug effects; D013329:Structure-Activity Relationship; D014132:Trachea / Q000187:drug effects; D014316:Tritium
D000588:Amines; D000959:Antihypertensive Agents; D007093:Imidazoles; D011941:Receptors, Adrenergic; D014316:Tritium; D012110:Reserpine; D009638:Norepinephrine